Literature DB >> 12084733

Surgery for glaucoma in the 21st century.

P T Khaw, A P Wells, K S Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12084733      PMCID： PMC1771181          DOI： 10.1136/bjo.86.7.710

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Viscocanalostomy for open-angle glaucoma in black African patients.

Authors:  R Stegmann; A Pienaar; D Miller
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

2.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

Review 3.  Glaucoma drainage devices; past, present, and future.

Authors:  K S Lim; B D Allan; A W Lloyd; A Muir; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

4.  Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: A randomized clinical trial.

Authors:  C Jonescu-Cuypers; P Jacobi; W Konen; G Krieglstein
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

5.  Experimental flow studies in glaucoma drainage device development.

Authors: 
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

6.  Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma.

Authors:  F El Sayyad; M Helal; H El-Kholify; M Khalil; A El-Maghraby
Journal:  Ophthalmology       Date:  2000-09       Impact factor: 12.079

7.  Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery.

Authors:  D Chiselita
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

8.  Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study.

Authors:  Dilani Siriwardena; Peng T Khaw; Anthony J King; Mark L Donaldson; Barry M Overton; Clive Migdal; M Francesca Cordeiro
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

9.  Cataract induction in lenses cultured with transforming growth factor-beta.

Authors:  A M Hales; C G Chamberlain; J W McAvoy
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-07       Impact factor: 4.799
  9 in total
  5 in total

1.  Surgery for glaucoma in the 21st century.

Authors:  T Shaarawy
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Surgery for glaucoma.

Authors:  P T Khaw; A P Wells; K S Lim
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification.

Authors:  C E Traverso; F De Feo; A Messas-Kaplan; P Denis; S Levartovsky; E Sellem; F Badalà; Z Zagorski; A Bron; S Gandolfi; M Belkin
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.

Authors:  Alexandre Bissig; Michael Feusier; André Mermoud; Sylvain Roy
Journal:  Int Ophthalmol       Date:  2010-06-16       Impact factor: 2.031

5.  Incidence of iris colour change in latanoprost treated eyes.

Authors:  M A Teus; E Arranz-Márquez; P Lucea-Suescun
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.